LOVENOX® is indicated to help reduce the risk of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE). Read full important safety. /83/EC for Lovenox and associated names, in order to resolve divergences The PI was split as follows according to the indications the. Save money on your Lovenox® Injection prescription by switching to Teva’s FDA- approved generic version, Enoxaparin Sodium Injection, USP.

Author: Shagar Dalar
Country: Haiti
Language: English (Spanish)
Genre: Marketing
Published (Last): 14 June 2013
Pages: 170
PDF File Size: 16.40 Mb
ePub File Size: 5.15 Mb
ISBN: 591-8-13131-130-5
Downloads: 66239
Price: Free* [*Free Regsitration Required]
Uploader: Nikozahn

It is not known whether Lovenox is excreted in human milk.

The second infusion of 0. The source of the gender difference in these parameters has not been conclusively identified; however, body weight may be a contributing factor. The average duration of administration is 7 days; up to 17 days of Lovenox administration has been administered in controlled clinical trials. Lovenox must not be administered by intramuscular injection.

All patients were treated with aspirin for a minimum of 30 days. Use of Lovenox in patients with a history of immune-mediated HIT within the past days or in the presence lovejox circulating antibodies is contraindicated [see Contraindications 4 ]. In patients undergoing hip or knee replacement surgery, the recommended dose of Lovenox is 30 mg every 12 hours administered by subcutaneous injection.

Enoxaparin Sodium Injection, USP

A total of patients were randomized in the study and patients were treatedof which 99 had total knee replacement and 32 lovejox either unicompartmental knee replacement or tibial osteotomy. Steady-state enoxaparin activity levels are well predicted by single-dose pharmacokinetics. Enoxaparin was not mutagenic in in vitro tests, including the Ames test, mouse lymphoma cell forward mutation test, and human lymphocyte chromosomal aberration test, and the in vivo rat bone marrow chromosomal aberration test.

Pregnant women with thromboembolic disease, including those with mechanical prosthetic heart valves and those with inherited or acquired thrombophilias, have an increased risk of other maternal complications and fetal loss regardless of the type of anticoagulant used.

Very rare cases of hyperlipidemia lovenod also been reported, with one case of hyperlipidemia, with marked hypertriglyceridemia, reported in a diabetic pregnant woman; po has not been determined. Remove the prefilled syringe from the blister packaging by peeling at the arrow as directed on the blister.


Obtain hemostasis at the puncture site before sheath removal 5. Retroperitoneal, intraocular, and intracranial hemorrhages were always considered major. Pregnant women should be apprised of the potential hazard to the fetus and the mother locenox enoxaparin is administered during pregnancy. Use of indwelling epidural catheters Concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs NSAIDsplatelet inhibitors, other anticoagulants A history of traumatic or repeated epidural or spinal punctures A history of spinal deformity or spinal surgery Optimal timing between the administration of Lovenox and neuraxial procedures is not known Monitor patients frequently for signs and symptoms of neurological impairment.

Instruct patients to report immediately if they experience any of the above signs or symptoms.

The minimum amount of benzyl alcohol at which serious adverse reactions may occur is not known Lovenox multiple-dose vials contain 15 mg of benzyl alcohol per mL [see Use in Specific Populations 8. In both outpatient and inpatient hospital treatments, warfarin sodium therapy should be initiated when appropriate usually within 72 hours of Lovenox. Because fatal reactions, often resembling anaphylaxis, have been reported with protamine sulfate, it should be given only when resuscitation techniques and treatment of anaphylactic shock are readily available.

In a study of extended prophylaxis for patients undergoing hip replacement surgery, patients were treated, while hospitalized, with Lovenox 40 mg subcutaneously, initiated up to 12 hours prior to surgery for the prophylaxis of postoperative DVT. Periodic complete lovenkx counts, including platelet count, and stool occult blood tests are recommended during the course of treatment with Lovenox. Fetal Risk Summary Lovenox does not cross the placenta, and is not expected lovenoxx result in fetal exposure to the drug.

TGA eBS – Product and Consumer Medicine Information

After repeated subcutaneous administration of 40 mg once daily and 1. It is not known if monitoring of anti-Factor Xa activity and dose adjustment by weight or anti-Factor Xa activity of Lovenox affect the safety and the efficacy of the drug during pregnancy. Use with caution in patients at risk 5. Kaplan-Meier Plot — Death or Myocardial Re-infarction at 30 Days — ITT Population There is a trend in favor of enoxaparin during the first 48 hours, but most of the treatment difference is attributed to a step increase in the event rate in the UFH group at 48 hours seen in Figure 2an effect that is more striking when comparing the event rates just prior to and just subsequent to actual times of discontinuation.


Significant anti-Factor Xa activity persists in plasma for about 12 hours following a 40 mg subcutaneous once a day dose. During clinical development for the approved indications, 15, patients were exposed to enoxaparin sodium. Hemodialysis In a single study, elimination rate appeared similar but AUC was two-fold higher than control population, after a single 0. Causality for these cases has not been determined.

Teva’s generic of Lovenox® Injection: Enoxaparin Sodium Injection, USP

Subcutaneous Injection Technique Patients should be lying down and Lovenox administered by deep subcutaneous injection. Keep out of the reach of children. No ppi adjustment is necessary for other indications in geriatric patients unless kidney function is impaired [see Dosage and Administration 2.

Steady state is achieved on the second day of treatment. Activation of the safety system must be done only after removing the needle from the patient’s skin. The lower incidence of the triple endpoint was sustained up to 30 days after initiation of treatment.


The 99 patients with total knee replacement ranged in age from 42 to 85 years mean age A total of patients were randomized in the study and all patients were treated.

Lovenox is available in two concentrations see Tables 26 and To minimize bruising, do not rub the injection site after completion of the injection. Patients ranged in age from 18 to 92 years mean age In a multicenter, double-blind, double-dummy, parallel-group study, patients with acute ST-segment elevation myocardial infarction STEMI who were to be pu within 6 hours of onset and were eligible to receive fibrinolytic therapy were randomized in a 1: